Evidence map›Paper›PMID 21360574›Full record

ArticleJournal of neuroscience research2011

Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase.

Janet L Rossi, Hantamalala Ralay Ranaivo, Fatima Patel, Maryann Chrzaszcz, Charu Venkatesan, Mark S Wainwright

Abstract read
In one paragraph

Article in Journal of neuroscience research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. The association between lactate to albumin ratio and outcomes at early phase in patients with traumatic brain injury.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023
    Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Janet L RossiDepartment of Pediatrics, Divisions of Critical Care, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.
Hantamalala Ralay Ranaivo
Fatima Patel
Maryann Chrzaszcz
Charu Venkatesan
Mark S Wainwright
Lurie Children's Hospital · USNorthwestern University · USNorthwestern Memorial Hospital · US

Funding

Faculty Development Program for Pediatric Clinician-ScientistsK12HD052902 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI GREEN, THOMAS P. · 2006 to 2010
$1.6M
Glial Activation Following Perinatal Hypoxia-IschemiaK08NS044998 · NINDS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI WAINWRIGHT, MARK STEPHEN · 2004 to 2008
$821k
NICHD NIH HHS K12 HD052902NINDS NIH HHS K08 NS044998
6 · The paper itself

Abstract

Myosin light chain kinase (MLCK) plays an important role in the reorganization of the cytoskeleton, leading to disruption of vascular barrier integrity in multiple organs, including the blood-brain barrier (BBB), after traumatic brain injury (TBI). MLCK has been linked to transforming growth factor (TGF) and rho kinase signaling pathways, but the mechanisms regulating MLCK expression following TBI are not well understood. Albumin leaks into the brain parenchyma following TBI, activates glia, and has been linked to TGF-β receptor signaling. We investigated the role of albumin in the increase of MLCK in astrocytes and the signaling pathways involved in this increase. After midline closed-skull TBI in mice, there was a significant increase in MLCK-immunoreactive (IR) cells and albumin extravasation, which was prevented by treatment with the MLCK inhibitor ML-7. Using immunohistochemical methods, we identified the MLCK-IR cells as astrocytes. In primary astrocytes, exposure to albumin increased both isoforms of MLCK, 130 and 210. Inhibition of the TGF-β receptor partially prevented the albumin-induced increase in both isoforms, which was not prevented by inhibition of smad3. Inhibition of p38 MAPK, but not ERK, JNK, or rho kinase, also prevented this increase. These results are further evidence of a role of MLCK in the mechanisms of BBB compromise following TBI and identify astrocytes as a cell type, in addition to endothelium in the BBB, that expresses MLCK. These findings implicate albumin, acting through p38 MAPK, in a novel mechanism by which activation of MLCK following TBI may lead to compromise of the BBB.

Indexed as

AlbuminsAnimalsAnimals, NewbornAstrocytesBrain InjuriesCells, CulturedDisease Models, AnimalEnzyme InhibitorsGene Expression RegulationGlial Fibrillary Acidic ProteinMiceMice, Inbred C57BLMyosin-Light-Chain Kinasep38 Mitogen-Activated Protein KinasesRatsRats, Sprague-DawleyAlbuminsEnzyme InhibitorsGlial Fibrillary Acidic ProteinMyosin-Light-Chain Kinasep38 Mitogen-Activated Protein Kinasesrho-Associated Kinases

Identifiers

PMID21360574
PMCPMC3079319
OpenAlexW2010781157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.